Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Telik and Sankyo enter drug screening collaboration

April 21, 1999

Aastrom launches stem cell therapy technology system in Europe

April 21, 1999

Potent, orally bioavailable NK3 antagonist under study at Warner-Lambert

April 19, 1999

Preparation, compositions and administration of new carrier compounds reported by Emisphere

April 15, 1999

SBIR grant to Genetronics for gene therapy delivery research

April 15, 1999

Epicyte awarded SBIR and DARPA grants

April 14, 1999

Isis and Elan sign antisense agreement

April 14, 1999

Delsys and R.W. Johnson to collaborate on solid oral drug delivery technology

April 12, 1999

Metabolic Modulators and Chugai sign drug discovery agreement

April 9, 1999

CyDex and Allergan sign Captisol licensing agreement

April 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...